Single state body for drug pricing and turnover control soon be established in Ukraine

2 February 2015

A single state body for the control of pricing and the turnover of drugs will soon be established in Ukraine, as part of the ongoing reforms of the country’s pharmaceutical market, reports The Pharma Letter’s local correspondent.

According to the Ukrainian Ministry of Health, the setting up of the new state body is part of the plans of the Ukrainian government for harmonization of the national legislation in the field of pharmaceuticals with European regulations.

It is planned that the establishment of the new state body will allow for the elimination of a significant part of bureaucratic hurdles, which currently exist in the Ukrainian pharmaceutical market and will ease the procedure of license granting, and in particular to importers.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >